Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
1992-12-08
2002-04-02
Wang, Andrew (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C536S023200, C435S006120, C435S091310, C435S375000
Reexamination Certificate
active
06365730
ABSTRACT:
BACKGROUND OF THE INVENTION
Throughout this application various publications are referred to by author and year within brackets. The full references are listed alphabetically after the Experimental Section. The disclosures for these publications in their entireties are hereby incorporated by reference into this application to more fully describe the state of the art to which this invention pertains.
Ribozymes are RNA molecules that can cut or ligate other nucleic-acid molecules (usually RNA) in a catalytic fashion (Cech and Bass, 1986; Altman, et al., 1987). The hammerhead ribozyme is one of the best-known ribozymes. It has been studied extensively in isolated chemical systems (Forster and Symons, 1987; Uhlenbeck, 1987; Haseloff and Gerlach, 1988; Jeffries and Symons, 1989; Koizumi, et al., 1988), and used in gene-control studies in living cells (Cotten and Birnstiel, 1989; Cameron and Jennings, 1989; Sarver, et al., 1990; Saxena and Ackerman, 1990; Sioud and Drlica, 1991; Sioud, et al., 1992). A hammerhead ribozyme as defined by Haseloff and Gerlach (Haseloff and Gerlach, 1988) is shown in FIG.
1
. It contains two stretches of conserved nucleotides (boxed), a stem-loop structure (bases 18-29) containing helix II, and flanking nucleotides which form double-helices I and III in combination with the substrate.
The instability of ribozymes in living cells is a major concern. One approach taken to protect transcribed ribozymes from nuclease attack in cells has been to embed the ribozyme in a larger, folded structure. Thus, hammerhead ribozymes have been placed next to the anti-codon loop in t-RNA
met
(Cotten and Birnstiel, 1989), the 3′ untranslated region of the luciferase gene (Cameron and Jennings, 1989), and in a molecule with bacteriophage T7 transcription terminator at its 3′ end (Sioud, et al, 1992). These ribozymes appeared to be more stable than the corresponding, unprotected ribozymes; however, in the only comparative study, the stabilized ribozyme did not cleave more target RNA than the shorter-lived ribozyme, indicating that the protecting structure may decrease the specific activity of that ribozyme (Sioud, et al., 1992).
An alternative approach has been to chemically synthesize ribozymes with ribonucleotides modified at the 2′ position. The modified nucleotides have included 2′-deoxy- 2′fluoro-, 2′-amino-, 2′-O-allyl- and 2′-O-methyl-ribonucleotides (Perreault, et al., 1990; Perreault, et al., 1991; Olsen, et al., 1991; Pieken, et al., 1991; Williams, et al., 1992; Paolella, et al., 1992). A ribozyme consisting predominantly of 2′-O-allyl ribonucleotides displayed greatly improved stability compared to an unmodified ribozyme in the presence of bovine serum (Paolella, et al., 1992). Modifications to nucleotides in the hybridizing arms and/or in helix II of the ribozyme have little effect on catalytic efficiency (Olsen, et al., 1991; Pieken, et al., 1991; Williams, et al., 1992; Paolella, et al., 1992); for example, substitution of the 2′-hydroxyl groups with 2′-O-allyl groups in all non-conserved nucleotides of a hammerhead ribozyme resulted in full retention of activity (Paolella, et al., 1992). On the other hand, changing the 2′-substituent in any of the conserved nucleotides of the ribozyme resulted in a decrease in catalytic activity, the magnitude of which varied greatly depending on the number of changes, the nature of the change, and the particular nucleotides modified (Perreault, et al., 1990; Perreault, et al., 1991; Olsen, et al., 1991; Pieken, et al., 1991; Williams, et al., 1992; Paolella, et al., 1992).
SUMMARY OF THE INVENTION
The invention describes catalytic nucleic acid based compounds capable of cleaving nucleic acid polymers both in vivo and in vitro. Two embodiments of this invention are compounds with a short stem that does not base pair, a minizyme, and compounds with DNA hybridizing arms and RNA catalytic domain and stem, DNA-armed ribozymes. The compounds of this invention, while nucleotide based may be substituted or modified in the sugar, phosphate, or base. Methods of use and methods of treatment are also described.
REFERENCES:
patent: 4511713 (1985-04-01), Miller et al.
patent: 4987071 (1991-01-01), Cech
patent: 5023243 (1991-06-01), Tullis et al.
patent: 5144019 (1992-09-01), Rossi et al.
patent: 5149796 (1992-09-01), Rossi
patent: 5298612 (1994-03-01), Jennings et al.
patent: 5972701 (1999-10-01), Jennings
patent: 6001989 (1999-12-01), Jennings
patent: 6008343 (1999-12-01), Jennings
patent: 6083744 (2000-07-01), Jennings
Branch TIBS—Feb. 1998 pp. 45-50.*
Olsen et al. Biochemistry 30: 9735-9741, 1991.*
Odai et al. FEBS 267: 150-152, Jul. 1990.*
Pieken et al. Science 253:314-317, Jul. 1991.*
Stull et al. Pharm. Res. 12:465-483 (1995).*
Cameson et al. PNAS 86:9139-9143 (1989).*
Boehm, S., (1987) FEBS Letter 220:283-287 (Ex. 8).
Bruening, G. (1989) Methods of Enzym. 180:546-558 (Ex. 9).
Cech, T.R. (1987) Science 236:1532-1539 (Ex. 10).
Chuat, J., et al. (1989) Biochem. & Biophys. Res. Comm. 162:1025-1029 (Exhibit 12).
Cotten, M., et al. (1989) The EMBO Journal 8:3861-3866 (Ex. 13).
Dahm, S.C., et al. (1990) Biochimie 72:819-823 (Ex. 14).
Eckner, R. et al., (1991) The EMBO Journ. 10:3513-3522 (Ex. 15).
Forster, A.C. et al. (1988) NAture 334:265-267 (Ex. 16).
Goodchild, J., et al. (1991) Archives to Biochem & Biophys. 284(2):386-391 (Ex. 18).
Goodchild, J. et al. (1990) Poster No. 12 at Conf in San Diego(Ex.
Haseloff, et al. (1988) Nature 334:585-591 (Ex. 19).
Huillier, A. et al. Abstract from Conf. proceedings (Ex. 20).
Hutchins, C.J. et al. (1986) Nucleic Acids Research 14:3627=3635 (Exhibit 21).
Jefferies, A.C., et al. (1989) Nucl. Acids Res. 17:1371-1377 (Exhibit 22).
Kikuchi, Y., et al., (1991) Nucleic Acids Res. 19:6715-6755 (Ex. 2.
Koizumi, et al., (1988) FEBS Letters 228:228-230 (Ex. 24).
Koizumi, et al. (1989) Nucleic Acids Res. 17:7059-7071 (Ex. 25).
Lamb, J.W., et al. (1990) J. Gen. Virol. 71:2257-2264 (Ex. 26).
McClain et al. (1987) Science 238:527-530 (Ex. 27).
Miller et al. (1991) Virology 183:711-720 (Ex. 28).
Perreault, J-P, et al. (1991) Biochem. 30:4020-4025 (Ex. 29).
Ruffner, D.E. et al. (1989) Gene 82:31-41 (Ex. 30).
Ruffner, D.E. et al. (1990) Biochemistry 29:10695-10702 (Ex. 31).
Sampson, et al. (1987) Cold Spring Harbor Sym Quant. Biol. 52:267-275 (Exhibit 32).
Sarver, et al. (1990) Science 247:1222-1224 (Exhibit 33).
Saxena, et al. (1990) J. Biol. Chem. 265:17106-17109 (Ex. 4).
Scanlon, K. et al. (1991) Proc. Natl. Acad. Sci. 88:10591-10595 (Exhibit 34).
Sheldon, C.C. et al. (1989) Nucleic Acids Res. 17:5665-5678 (Ex. 35.
Symons, R.H. (1989) Tibs, 14:445-450 (Exhibit 36).
Tabler, M. et al. (1991) Gene 108:175-183 (Exhibit 37).
Uhlenbeck, et al. (1987) Nature 328:596-600 (Ex. 38).
Yang, et al. (1990) Biochemistry 29:11156-11160 (Ex. 39).
Zaug, et al. (1986 A) Science, 231:473-474 (Exhibit 40).
Zaug, et al. (1986 B) Nature 234:429-433 (Exhibit 41).
Perreault et al. (1990) Nature, 344:565-567.
Forster et al. (1987) Cell 50:9-16.
Uhlmann et al. (1990) Chem. Revs. 90:544-584.
Hendry Philip
Jennings Philip Anthony
McCall Maxine June
Cooper & Dunham LLP
Gene Shears Pty. Limited
Wang Andrew
White John P.
LandOfFree
DNA-Armed ribozymes and minizymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA-Armed ribozymes and minizymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA-Armed ribozymes and minizymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2850952